1-4 of 4
Ahmad Mukhtar Khalid, MSc, PhD
Close
Sort by
Journal Articles

Detection of Compound BCR-ABL Mutations in TKI Resistant CML Patients Including a Novel K245N Mutation Associated with Primary Nilotinib Resistance By Employing a Newly Developed Cost Effective BCR-ABL Sequencing Protocol

Zafar Iqbal, MPhil PhDPost-Doctorate, Tanveer Akhtar, PhDPost-Doctorate, Afia M Akram, Muhammad Khalid, MS PhD, Ijaz Husssain Shah, MBBS FCPS, Aamir Aleem, MBBS MRCP FRCPath, Muhammad Khalid, MBBS FCPS, Javed Iqbal, MBBS FCPS, Zeba Aziz, MD MBBS, Muhammad Absar, MSc, Jamil Amjad Hashmi, PhDPost-Doctorate, Mehmood Husssain Qazi, PhD, Ahmad Mukhtar Khalid, MSc, PhD, Muhammad Farooq Sabar, PhD, Sajjad Karim, PhD, Mahmood Rasool, MSc PhD, Aamir Mahmood, PhD, Ammara Tariq Gill, MD, Giuseppe Saglio, MD, Mudassar Iqbal, MD
Journal: Blood
Blood (2014) 124 (21): 1810.
https://doi.org/10.1182/blood.V124.21.1810.1810
Published: 2014
Journal Articles

High Frequency Of BCR-ABL/t(22;9) Translocation As Detected By RT-PCR and Interphase FISH In Pediatric B-Cell ALL Patients Identifies The Need For Immediate Inclusion Of Tyrosine Kinase Inhibitors In Pediatric ALL Treatment Protocols

Zafar Iqbal, MPhil PhD Post-doctorate, Tashfin Awan, MSc PhD, Tanveer Akhtar, MSc, PhD, Aleem Aamer, MBBS MRCP FRCPath, Noreen Sabir, MSc PhD, Muhammad Absar, MSc, Iqbal Mudassar, MD MS, Ahmad Mukhtar Khalid, MSc, PhD, Giuseppe Saglio, MD, Mahmood Rasool, Akhtar Hussain, BS MPhil
Journal: Blood
Blood (2013) 122 (21): 3908.
https://doi.org/10.1182/blood.V122.21.3908.3908
Published: 2013
Journal Articles

BCR-ABL Splice Variants In Three Phases Of CML: Association With Disease Biology and Response To Imatinib

Iqbal Zafar, MPhil PhD Postdoctorate, Saba Shahzadi, Tanveer Akhtar, MSc, PhD, Aleem Aamer, MBBS MRCP FRCPath, Ahmad Mukhtar Khalid, MSc, PhD, Iqbal Mudassar, MD MS
Journal: Blood
Blood (2013) 122 (21): 5191.
https://doi.org/10.1182/blood.V122.21.5191.5191
Published: 2013
Journal Articles

Presence of Prior-to-Treatment BCR-ABL Mutations In CD34+CD38- Stem Cells of Newly Diagnosed Chronic Phase CML Patients and Their Correlation with Imatinib Resistance: Implications of Cancer Pharmacogenomics and Pre-Therapeutic Genetic Testing In Personalized Treatment of BCR-ABL+ Leukemia

Zafar Iqbal, BSc, MSc, MPhil, PhD, Mudassar Iqbal, MD, Tanveer Akhtar, MSc, PhD, Mubashar Iqbal Naqvi, BS(CS), Ammara H Tahir, MBBS, Tariq Jameel Gill, MBBS, Muhammad Naeem Abbas, MLT, Abid Jamil, MBBS, PhD, Abid Sohail Taj, MBBS, PhD, Dr Abd-Al-Qayyum, MD, Najeeb ur-Rehman, BS, (Engg), Muhammad Ferhan, MSc, MPhil, Ijaz Hussain Shah, MBBS, FCPS, Muhammad Khalid, MBBS, FCPS, Weng Xian Qin, BSc(MLT), MS, Ahmad Mukhtar Khalid, MSc, PhD, Mahwish Khan, Aamer Aleem, MD, Shahid Mahmood Baig, MPhil, PhD
Journal: Blood
Blood (2010) 116 (21): 2278.
https://doi.org/10.1182/blood.V116.21.2278.2278
Published: 2010